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Summary	31	 Genome-wide	association	studies	have	 linked	polymorphisms	 in	 the	autophagy	32	 gene	ATG16L1	with	 susceptibility	 to	 inflammatory	 bowel	 disease	 (IBD).	33	 However,	the	cell-type	specific	effects	of	autophagy	on	the	regulation	of	chronic	34	 intestinal	inflammation	have	not	been	investigated.		Here,	we	assessed	the	effect	35	 of	myeloid-specific	or	 intestinal	epithelial	cell	 (IEC)-specific	deletion	of	Atg16l1	36	 on	chronic	colitis	triggered	by	the	intestinal	opportunistic	pathogen	Helicobacter	37	
hepaticus	 in	mice.	Although	Atg16l1-deficiency	 in	myeloid	 cells	 had	 little	 effect	38	 on	 disease,	 mice	 selectively	 lacking	 Atg16l1	 in	 IEC	 (Atg16l1VC)	 developed	39	 severely	 exacerbated	 pathology,	 accompanied	 by	 elevated	 pro-inflammatory	40	 cytokine	secretion	and	increased	IEC	apoptosis.	Using	ex	vivo	IEC	organoids,	we	41	 demonstrate	that	autophagy	intrinsically	controls	TNF-induced	apoptosis	and	in	42	
vivo	blockade	 of	 TNF	 attenuated	 the	 exacerbated	 pathology	 in	Atg16l1VC	mice.	43	 These	findings	suggest	that	the	IBD	susceptibility	gene	ATG16L1	and	the	process	44	 of	 autophagy	 within	 the	 epithelium	 controls	 inflammation-induced	 apoptosis	45	 and	barrier	integrity	to	limit	chronic	intestinal	inflammation.	 	46	
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Introduction	47	 Inflammatory	 bowel	 disease	 (IBD)	 is	 a	 chronic	 inflammatory	 disorder	 with	48	 unknown	 etiology,	 with	 two	 main	 clinical	 forms	 –	 Crohn’s	 disease	 (CD)	 and	49	 ulcerative	 colitis	 (UC).	 Although	 there	 are	 broadly	 conserved	 features	 of	50	 intestinal	immunopathology	that	present	in	IBD	patients,	including	dysregulated	51	 immune	 responses,	 aberrant	 cytokine	 secretion,	 and	 alterations	 in	 barrier	52	 function	and	intestinal	microbiota	(Maloy	and	Powrie,	2011;	Neurath,	2014),	the	53	 clinical	 manifestations	 are	 heterogeneous	 (Lonnfors	 et	 al.,	 2014).	 The	54	 heterogeneous	nature	of	IBD	is	further	emphasized	by	genome	wide	association	55	 studies	(GWAS)	that	have	 identified	many	pathways	that	potentially	contribute	56	 to	the	pathogenesis	of	IBD	(Jostins	et	al.,	2012;	Liu	et	al.,	2015),	and	which	allow	57	 further	 stratification	 of	 patients,	 besides	 disease	 manifestations	 and	58	 immunological	 profiling	 (de	 Souza	 et	 al.,	 2017).	 Much	 current	 IBD	 research	59	 focuses	on	unraveling	 the	mechanistic	effects	of	genes	and	pathways	 that	have	60	 been	implicated	by	GWAS.	A	better	understanding	of	how	host	genetics	control	61	 disease	development	and	progression	should	enable	treatments	to	be	utilized	in	62	 more	 effective	 and	 cost-efficient	 manner.	 Current	 treatment	 options	 for	 IBD	63	 include,	 anti-inflammatory	 and	 immune-suppressive	 drugs,	 surgery,	 and	64	 biologics	that	specifically	target	the	dysregulated	immune	response	(Chang	and	65	 Hanauer,	2017).	In	the	latter	category,	anti-TNF	treatment	has	high	efficacy	and	66	 has	been	increasingly	employed,	however	40	%	of	IBD	patients	do	not	respond	67	 to	 this	 therapy	 and	many	 become	 refractory	 to	 treatment	 (Cohen	 and	 Sachar,	68	 2017;	Hendy	et	al.,	2016).	As	it	is	not	fully	understood	how	anti-TNF	treatment	69	 acts	and	which	cell	types	are	targeted,	it	is	difficult	to	predict	which	patients	are	70	 most	likely	to	benefit	and	what	mechanisms	prevent	responsiveness.	71	
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Polymorphisms	 in	 ATG16L1	 and	 other	 autophagy	 genes	 suggest	 an	 important	72	 role	of	autophagy	 in	 IBD	pathogenesis	 (Hampe	et	al.,	2007;	Rioux	et	al.,	2007).	73	
ATG16L1	 is	 an	 essential	 autophagy	 gene	 and	 the	 T300A	 polymorphism	 that	74	 shows	 the	 strongest	 link	 to	 IBD	 development	 results	 in	 destabilization	 of	 the	75	 protein,	 facilitating	 caspase	 3	 dependent	 degradation	 during	 cellular	 stress	76	 (Mizushima	 et	 al.,	 2011;	 Murthy	 et	 al.,	 2014).	 Autophagy	 is	 a	 conserved	77	 intracellular	 degradation	 pathway	 that	 facilitates	 maintenance	 of	 cellular	78	 homeostasis	 during	 periods	 of	 stress	 or	 malnutrition,	 but	 it	 also	 impacts	 on	79	 many	pathways	of	cellular	immune	defense	(Kabat	et	al.,	2016b).	The	ubiquitous	80	 nature	of	autophagy	and	its	interactions	with	many	other	essential	homeostatic	81	 cellular	processes	makes	it	difficult	to	unravel	precisely	how	disease-associated	82	 polymorphisms	 can	 predispose	 to	 IBD.	 Nevertheless,	 several	 studies	 have	83	 described	 cell-type	 specific	 functions	 of	 autophagy	 in	 the	 context	 of	 mucosal	84	 homeostasis	(Adolph	et	al.,	2013;	Cadwell	et	al.,	2008;	Kabat	et	al.,	2016a;	Kabat	85	 et	 al.,	 2016b;	 Saitoh	 et	 al.,	 2008).	 In	 myeloid	 cells	 autophagy	 is	 implicated	 in	86	 regulation	 of	 the	 proinflammatory	 cytokine	 response,	 particularly	 secretion	 of	87	 inflammasome	dependent	cytokines	and	ROS	levels	are	increased	in	autophagy-88	 deficient	 macrophages	 (Lassen	 et	 al.,	 2014;	 Saitoh	 et	 al.,	 2008;	 Zhang	 et	 al.,	89	 2017).	 Bone-marrow	 chimeric	 mice	 with	 autophagy-deficient	 haematopoetic	90	 cells,	 Atg16l1-hypomorphic	 mice	 or	 mice	 lacking	 Atg16l1	 in	 the	 myeloid	91	 compartment	all	 show	 increased	pathology	 in	 the	chemically	 induced	model	of	92	 DSS	colitis	(Cadwell	et	al.,	2010;	Saitoh	et	al.,	2008;	Zhang	et	al.,	2017).		Although	93	 autophagy	enhances	killing	of	Salmonella	by	DCs	and	macrophages	in	vitro,	how	94	 much	this	impacts	on	disease	development	during	infection	is	less	clear	(Conway	95	 et	 al.,	 2013;	 Thurston	 et	 al.,	 2012;	 Zhang	 et	 al.,	 2017).	 Recent	 studies	 also	96	
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revealed	 that	autophagy	 in	T	cells	 is	required	 for	 the	maintenance	of	 intestinal	97	 homeostasis,	 as	Treg	 cells	 rely	 on	 autophagy	 for	 their	 survival	 and	 function	 in	98	 the	gut	(Kabat	et	al.,	2016a;	Wei	et	al.,	2016).	Autophagy	has	also	been	reported	99	 to	regulate	many	key	functions	of	intestinal	epithelial	cells	(IEC).	Autophagy	has	100	 been	shown	to	influence	granule	structure	of	goblet	and	Paneth	cells	(secretory	101	 cells	 of	 the	 intestinal	 epithelium)	 under	 stressed	 conditions,	 such	 as	 during	102	 norovirus	infection	or	ER	stress	(Adolph	et	al.,	2013;	Cadwell	et	al.,	2010;	Lassen	103	 et	al.,	2014;	Patel	et	al.,	2013).	Epithelial	autophagy	has	also	been	implicated	in	104	 barrier	enforcement	during	Salmonella	infection,	as	autophagy-deficiency	of	IEC	105	 led	 to	 increased	 bacterial	 dissemination	 and	 inflammation	 (Benjamin	 et	 al.,	106	 2013;	Conway	et	al.,	2013;	Lassen	et	al.,	2014).		107	 Taken	 together,	 these	 studies	 indicate	 that	 autophagy	 has	 wide-ranging	108	 functional	 effects	 on	 various	 cell	 types	 that	 could	 potentially	 regulate	109	 inflammatory	 responses.	 However,	 thus	 far,	 there	 have	 been	 few	 comparative	110	 studies	of	the	cell-type	specific	effects	of	autophagy	on	the	regulation	of	chronic	111	 intestinal	inflammation.	Here,	we	have	undertaken	a	comprehensive	analysis	of	112	 the	 consequences	 of	 autophagy	 deficiency	 within	 different	 cellular	113	 compartments	 on	 chronic	 intestinal	 pathology.	 We	 have	 utilized	 a	 well-114	 characterized	 mouse	 IBD	 model	 in	 which	 chronic	 intestinal	 inflammation	 is	115	 induced	 by	 infection	 with	 the	 gram	 negative	 enteric	 bacterium	 Helicobacter	116	
hepaticus	 together	 with	 concomitant	 blockade	 of	 immune	 regulatory	 circuits	117	 using	anti-IL10R	(Kullberg	et	al.,	2006).	Our	previous	work	has	shown	that	this	118	 model	recapitulates	several	features	of	chronic	intestinal	pathology	found	in	IBD	119	 patients,	 that	 pathology	 is	 driven	 by	 similar	 excessive	 innate	 and	 adaptive	120	 immune	 responses,	 and	 that	 disease	 is	 controlled	 by	 the	 same	 key	 pro-121	
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inflammatory	 mediators	 (Hue	 et	 al.,	 2006;	 Kullberg	 et	 al.,	 2006;	 Maloy	 et	 al.,	122	 2003;	Schiering	et	al.,	2014;	West	et	al.,	2017).		We	find	that	selective	autophagy	123	 deficiency	in	myeloid	cells	only	marginally	affects	colitis	development,	whereas	124	 autophagy	 deficiency	 in	 IEC	 results	 in	 severely	 exacerbated	 pathology.	 We	125	 further	 show	 that	 autophagy	 regulates	 cytokine-induced	 apoptosis	 in	 IEC	 and	126	 blockade	of	TNF	attenuates	chronic	colitis	in	IEC-specific	Atg16l1-deficient	mice	127	 by	ameliorating	epithelial	apoptosis.		 	128	
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Results	129	
Autophagy-deficiency	 in	 intestinal	 epithelial	 cells	 (IEC)	 predisposes	 to	130	
chronic	colitis		131	 To	 analyze	 the	 cell-type	 specific	 role	 of	 autophagy	 in	 chronic	 intestinal	132	 inflammation,	 we	 crossed	 Atg16l1fl/fl	 mice	 (Hwang	 et	 al.,	 2012)	 with	 strains	133	 expressing	 Cre	 recombinase	 under	 the	 control	 of	 various	 cell-type	 specific	134	 promoters.	 Thus,	 we	 generated	 transgenic	 mice	 lacking	 Atg16l1	 in	135	 neutrophils/macrophages	(Atg16l1LysM),	in	dendritic	cells	(Atg16l1CD11c)	or	in	IEC	136	 (Atg16l1VC).	Analyses	of	Atg16l1	expression	by	quantitative	PCR	confirmed	that	137	 LysM-Cre	and	CD11c-Cre	driven	recombination	selectively	reduced	expression	of	138	
Atg16l1	 in	myeloid	 cell	 compartments	 (CD11c+,	 MHC2+,	 CD45+	 DC	 and	 CD64+,	139	 CD11b+,	 CD45+	 macrophages),	 whereas	 Villin-Cre	 driven	 recombination	140	 selectively	ablated	Atg16l1	expression	in	IEC	(Fig.	S1	A-C).		141	 Intestinal	 inflammation	 was	 induced	 by	 oral	 infection	 with	 Helicobacter	142	
hepaticus	 and	 blockade	 of	 the	 regulatory	 response	 with	 anti-IL10R	 antibody	143	 (Kullberg	et	al.,	2006)(Fig.	1	A).	To	exclude	any	potential	microbiota	differences,	144	 the	 transgenic	 lines	 were	 bred	 as	 heterozygous	 for	 the	 Cre	 allele,	 allowing	145	 experimental	groups	to	be	set	up	using	littermate	controls	(Atg16l1fl/fl)	that	were	146	 co-housed	throughout	the	experiment.	147	 At	two	weeks	after	colitis	induction,	assessment	of	histopathology	of	the	caecum	148	 and	 colon	 revealed	 slightly	 elevated	 pathology	 in	Atg16l1CD11c	 and	 Atg16l1LysM	149	 mice	 compared	 to	Atg16l1fl/fl	mice,	 but	 these	 differences	 were	 not	 statistically	150	 significant	 (Fig.	 1	 B,	 C).	 Comparison	 with	 the	 concurrent	 littermate	 controls	151	 confirmed	 that	 there	was	 only	 a	minor	 increase	 in	 pathology	 and	 revealed	 no	152	
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significant	 alterations	 within	 the	 lamina	 propria	 CD4+	 T	 cell	 compartments	 in	153	 either	Atg16l1CD11c	or	Atg16l1LysM	mice	(Fig.	S1	D-K).	154	 In	contrast,	Atg16l1VC	mice	showed	significantly	elevated	histopathology	in	both	155	 the	caecum	and	colon	at	2	weeks	and	4	weeks	after	colitis	induction	(Fig.	1	B	-	G).		156	 Although	 overall	 disease	 severity	 varied	 slightly	 between	 experiments,	 we	157	 consistently	 observed	 significantly	 increased	 histopathology	 in	Atg16l1VC	 mice	158	 compared	to	their	Atg16l1fl/fl	littermates.	This	was	in	accordance	with	increased	159	 weight	 loss	 in	 the	Atg16l1VC	mice	 (Fig.	 1	H)	 and	 increased	numbers	 of	 CD4+	T	160	 cells	 in	 the	 lamina	 propria	 compared	 to	 Atg16l1fl/fl	 littermates	 (Fig.	 1	 I).	161	 Furthermore,	secretion	of	inflammatory	cytokines,	such	as	TNF,	IFN-γ 	and	IL1-β,	162	 by	colon	explants	 isolated	 from	Atg16l1VC	mice	were	significantly	elevated	at	2	163	 weeks	 after	 colitis	 induction	 compared	 to	 explants	 obtained	 from	 Atg16l1fl/fl	164	 littermates	(Fig.	1	J-L).	However,	frequencies	of	CD4+	T	effector	and	Treg	subsets	165	 in	 the	 lamina	 propria	 and	 H.h.	 colonization	 levels	 were	 not	 altered	 in	 the	166	
Atg16l1VC	mice	 relative	 to	 their	Atg16l1fl/fl	littermates	 (Fig.	 S2).	We	 also	 tested	167	 the	role	of	intestinal	epithelial	autophagy	in	a	model	of	acute	intestinal	infection	168	 using	oral	 infection	with	Citrobacter	rodentium	(Collins	 et	 al.,	 2014).	We	 found	169	 that	 Citrobacter	 rodentium	 infection	 induced	 comparable	 levels	 of	 intestinal	170	 pathology	in	Atg16l1VC	mice	and	Atg16l1fl/fl	mice	(Fig.	S3	A,	B,	E,	F),	which	was	in	171	 accordance	 with	 similar	 bacterial	 colonization	 levels	 (Fig.	 S3	 C,	 D).	 Taken	172	 together,	 these	data	reveal	 that	autophagy	within	 IEC	exerts	a	protective	effect	173	 during	 Helicobacter	 hepaticus-triggered	 chronic	 colitis,	 whereas	 autophagy	 in	174	 myeloid	cell	 compartments	 (CD11c+	or	LysM+	cells)	plays	only	a	marginal	 role.	175	 Therefore,	we	 focused	 our	 further	 analyses	 on	 the	 consequences	 of	 autophagy	176	
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impairment	 in	 IEC	 and	 the	 impact	 that	 it	 has	 on	 the	 development	 of	 chronic	177	 colitis.	178	 	179	
Autophagy	does	not	regulate	chemokine	expression	or	ER	stress	induction	in	180	
IEC	181	 We	 next	 sought	 to	 analyze	 how	 autophagy-deficiency	 within	 the	 epithelium	182	 influences	colitis	development.	First,	we	noticed	that	 in	vivo	 IEC	from	Atg16l1VC	183	 mice	expressed	elevated	levels	of	chemokines	Cxcl2	and	Cxcl5	at	2	weeks	and	4	184	 weeks	after	colitis	induction	(Fig.	2	A,	B).		185	 To	 analyze	 whether	 the	 chemokine	 response	 of	 the	 epithelium	 is	 intrinsically	186	 controlled	 by	 autophagy,	 we	 employed	 the	 ex	 vivo	 organoid	 system	 to	 grow	187	 primary	 IEC	 from	 either	 Atg16l1fl/fl	or	 Atg16l1VC	 mice	 (Heijmans	 et	 al.,	 2013).	188	 Western	 blot	 analysis	 of	 LC3	 lipidation	 confirmed	 autophagy	 deficiency	 in	 IEC	189	 organoids	derived	 from	Atg16l1VC	mice	 (Fig.	 2	D).	 In	 the	presence	of	 complete	190	 medium	 containing	 the	 essential	 IEC	 growth	 factors	 (Wnt3a,	 R-spondin	 and	191	 noggin),	we	found	that	autophagy-deficient	colonic	IEC	proliferated	and	formed	192	 organoids	 that	 were	 morphologically	 indistinguishable	 from	 wild	 type	193	 organoids.		194	 To	mimic	 the	 conditions	 present	 in	 the	 inflamed	 intestine,	we	 isolated	 lamina	195	 propria	leucocytes	(LPL)	from	colitic	mice	(WT	mice	subjected	to	H.h.	+	αIL10R	196	 treatment	 for	2	weeks)	and	cultured	 them	overnight	 to	generate	 inflammatory	197	 conditioned	medium	(iCM)	that	was	harvested	from	the	culture	supernatant.	We	198	 then	 stimulated	Atg16l1fl/fl	or	Atg16l1VC	IEC	 organoids	with	 10%	 iCM	 to	 assess	199	 IEC	 responses	 to	 the	 colitic	microenvironment.	We	 found	 that	 both	Atg16l1fl/fl	200	 and	 Atg16l1VC	 IEC	 responded	 to	 stimulation	 with	 iCM,	 as	 evidenced	 by	 rapid	201	
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phosphorylation	 and	 nuclear	 translocation	 of	 Stat3	 (Fig.	 2	 C,	 D).	Western	 blot	202	 analysis	also	confirmed	robust	and	equivalent	activation	of	the	intracellular	Map	203	 kinase	pathway	in	response	to	iCM	stimulation	in	both	Atg16l1fl/fl	and	Atg16l1VC	204	 IEC	 (Fig.	 2	 D).	 In	 addition,	 Cxcl2	 and	 Cxcl5	 expression	 were	 induced	 to	205	 comparable	 levels	 in	Atg16l1fl/fl	and	Atg16l1VC	organoids	after	6h	of	 stimulation	206	 with	iCM	(Fig.	2	E,	F).		207	 In	order	to	test	the	response	of	primary	IEC	from	Atg16l1fl/fl	or	Atg16l1VC	mice	to	208	 bacterial	 stimulation,	 we	 adapted	 the	 primary	 IEC	 culture	 system	 to	 generate	209	 polarized	monolayers	(Moon	et	al.,	2013).	Thus,	IEC	organoids	from	Atg16l1fl/fl	or	210	
Atg16l1VC	mice	 were	 seeded	 as	monolayers	 and	 subsequently	 infected	 with	H.	211	
hepaticus	 at	 the	 apical	 surface.	 Autophagy	 deficiency	 of	 the	 IEC	 monolayer	212	 derived	from	Atg16l1VC	mice	was	again	verified	by	blotting	for	lipidated	LC3	(Fig.	213	 2	G).	We	found	that	both	WT	and	autophagy-deficient	IEC	rapidly	responded	to	214	
H.	 hepaticus	 infection,	 with	 comparable	 phosphorylation	 of	 Erk1/2	 and	 NFκB	215	 p65	 (Fig.	 2	 G).	 Furthermore,	 Cxcl2	 induction	 was	 also	 comparable	 between	216	
Atg16l1fl/fl	and	Atg16l1VC	IEC	at	6h	post	H.	hepaticus	infection	(Fig.	2	H).	217	 Taken	together,	the	ex	vivo	primary	IEC	stimulation	experiments	suggest	that	the	218	 exacerbated	 chemokine	 production	 observed	 in	 Atg16l1VC	mice	 during	 colitis	219	 (Fig.	2	A,	B)	is	a	consequence	of	the	elevated	inflammatory	environment,	rather	220	 than	any	intrinsic	hyperactivity	caused	by	autophagy	impairment	in	IEC.	221	 Several	recent	reports	have	linked	the	ER	stress	pathway	and	autophagy	in	the	222	 intestinal	 epithelium	 in	 the	 context	 of	 colitis	 (Adolph	 et	 al.,	 2013;	223	 Tschurtschenthaler	et	al.,	2017).	Therefore,	we	also	assessed	ER	stress	induction	224	 following	 iCM	 stimulation	 or	H.	hepaticus	 infection	 of	 primary	 IEC	 ex	 vivo.	We	225	 found	that	Grp78	expression	was	not	altered	following	iCM	stimulation	in	either	226	
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Atg16l1fl/fl	or	Atg16l1VC	IEC	organoids	(Fig.	2	I).	In	contrast,	H.	hepaticus	infection	227	 of	IEC	monolayers	resulted	in	comparably	increased	expression	of	Grp78	in	both	228	
Atg16l1fl/fl	and	Atg16l1VC	IEC	(Fig.	2	J).	Moreover,	phosphorylation	of	eIF2α	was	229	 also	increased	following	H.	hepaticus	infection;	and	again	the	levels	were	similar	230	 in	Atg16l1fl/fl	or	Atg16l1VC	 IEC	monolayers	(Fig.	2	K).	We	also	analyzed	markers	231	 of	 ER	 stress	 in	 IEC	 isolated	 from	 Atg16l1fl/fl	 or	 Atg16l1VC	 mice	 after	 colitis	232	 induction	with	H.	hepaticus	infection	and αIL10R	treatment.	Consistent	with	the	233	
in	 vitro	 data,	Grp78	 expression	was	 elevated	 to	 similar	 levels	 during	 colitis	 in	234	 both	Atg16l1fl/fl	and	Atg16l1VC	mice,	 both	 in	 isolated	 IEC	 fractions,	 as	well	 as	 in	235	 whole	colon	tissue	(Fig.	2	L,	M).		236	 Overall,	 these	 results	 suggest	 that,	 under	 these	 experimental	 conditions,	 ER	237	 stress	pathways	in	IEC	do	not	seem	to	be	influenced	by	the	presence	or	absence	238	 of	the	autophagy	pathway.	239	
	240	
Autophagy	deficiency	predisposes	IEC	to	apoptosis	241	 We	next	hypothesized	that	the	absence	of	a	functional	autophagy	pathway	might	242	 predispose	 IEC	 to	 cell	 death	 during	 inflammatory	 conditions	 (Marino	 et	 al.,	243	 2014).	To	assess	whether	autophagy	regulated	apoptosis	 in	 IEC	during	chronic	244	 colitis,	 we	 assessed	 the	 number	 of	 apoptotic	 cells	 by	 TUNEL	 staining.	 We	245	 observed	 increased	numbers	 of	TUNEL-positive	 IEC	 in	 both	 caecal	 and	 colonic	246	 sections	 of	Atg16l1VC	mice	 compared	 to	Atg16l1fl/fl	littermates	 at	 2	weeks	 after	247	 colitis	induction	(Fig.	3	A).	Moreover,	western	blot	analyses	of	intestinal	samples	248	 revealed	increased	levels	of	cleaved	caspase	8	in	isolated	IEC	lysates	and	whole	249	 colonic	 lysates	obtained	 from	Atg16l1VC	mice	compared	to	 those	obtained	 from	250	
Atg16l1fl/fl	littermates	(Fig	3	B,	C,	D).		251	
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To	determine	whether	the	increased	number	of	apoptotic	IEC	in	Atg16l1VC	mice	252	 was	 a	 consequence	 of	 the	 increased	 inflammation	 and	 elevated	 levels	 of	 pro-253	 inflammatory	 cytokines	 in	 Atg16l1VC	 mice,	 or	 whether	 autophagy	 intrinsically	254	 regulates	 apoptosis	 in	 IEC,	 we	 next	 assessed	 cytokine-induced	 apoptosis	 in	255	 primary	 IEC	 ex	 vivo.	 Organoids	 generated	 from	 Atg16l1fl/fl	 and	 Atg16l1VC	 mice	256	 were	 stimulated	 with	 40%	 iCM	 for	 24h	 and	 cell	 death	 and	 apoptosis	 were	257	 assessed	 in	parallel.	We	observed	 that	 cell	 death	 and	 caspase	3/7	 activity	was	258	 induced	 by	 iCM	 stimulation	 in	 both	Atg16l1fl/fl	and	Atg16l1VC	 IEC	 (Fig.	 4	 A,	 B),	259	 with	 increased	 caspase	 activation	 detected	 in	Atg16l1-deficient	 IEC	 (Fig.	 4	 B).	260	 Furthermore,	 blockade	 of	 TNF	 and	 IFN-γ	 through	 addition	 of	 monoclonal	261	 antibodies	 prevented	 cell	 death	 and	 apoptosis	 induction	 in	 IEC	 (Fig.	 4	 A,	 B),	262	 suggesting	 that	 these	 cytokines	 were	 largely	 responsible	 for	 the	 apoptosis	263	 induction	in	response	to	iCM.	Indeed,	stimulation	of	IEC	organoids	with	TNF	and	264	 IFN-γ induced	significantly	higher	levels	of	apoptosis	(Fig.	4	A,	B)	and	decreased	265	 metabolic	 activity	 	 (Fig.	 4	 C,	 D)	 in	 Atg16l1VC	 IEC	 organoids	 compared	 with	266	
Atg16l1fl/fl	organoids.	Western	blot	analysis	confirmed	increased	apoptosis	levels	267	 in	 the	 Atg16l1VC	 IEC	 organoids	 after	 stimulation	 with	 TNF	 and	 IFN-γ,	 as	 they	268	 showed	increased	cleavage	of	caspases	8	and	3	(Fig.	4	E)	and	staining	for	cleaved	269	 caspase	 3	 revealed	 increased	 numbers	 of	 apoptotic	 cells	 and	 disrupted	 cell	270	 morphology	(Fig.	4	F).		271	 To	 confirm	 that	 TNF	 induced	 elevated	 IEC	 apoptosis	 in	 Atg16l1VC	 mice,	 we	272	 assessed	 small	 intestinal	 epithelial	 cell	 apoptosis	 in	 mice	 that	 received	 an	273	 intraperitoneal	 injection	of	TNF	 (Vereecke	et	 al.,	 2014)	 (Fig.	 5A).	We	observed	274	 that	 Atg16l1VC	 mice	 lost	 significantly	 more	 weight	 than	 littermate	 controls	275	 following	TNF	injection	(Fig5	B).	Furthermore,	TUNEL	staining	of	small	intestinal	276	
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tissue	 sections	 revealed	 increased	 numbers	 of	 apoptotic	 IEC	 in	Atg16l1VC	mice	277	 compared	to	Atg16l1fl/fl	littermates	(Fig.	5	C)	and	this	correlated	with	increased	278	 cleavage	of	caspase	8	in	IEC	lysates	(Fig.	5	D,E).	279	 Taken	 together,	 these	 results	demonstrate	 that	 autophagy	 impairment	 renders	280	 IEC	 more	 responsive	 to	 apoptosis	 induction	 following	 exposure	 to	 the	 pro-281	 inflammatory	cytokine	milieu	present	in	the	inflamed	intestine.	282	 	283	
TNF	induced	apoptosis	drives	exacerbated	disease	in	Atg16l1VC	mice	284	 To	 functionally	 test	 whether	 TNF	 was	 the	 key	 driver	 of	 the	 increased	 IEC	285	 apoptosis	and	exacerbated	pathology	in	Atg16l1VC	mice	in	the	complex	setting	of	286	 chronic	 colitis,	 we	 induced	 colitis	 (H.	 hepaticus	 infection	 +	 anti-IL-10R	287	 treatment)	 in	Atg16l1VC	and	Atg16l1fl/fl	littermates	 and	 concomitantly	 treated	 a	288	 group	of	mice	with	a	blocking	antibody	against	TNF	(αTNF)	(Fig.	6	A).	We	found	289	 that,	 in	 contrast	 to	 their	 Atg16l1fl/fl	 littermates,	 Atg16l1VC	 mice	 exhibited	290	 significant	weight	loss	during	the	first	two	weeks	after	colitis	induction	and	that	291	 this	 was	 completely	 prevented	 by	 treatment	 with	 αTNF	 (Fig.	 6	 B).	292	 Furthermore, αTNF	 treatment	 also	 reduced	 intestinal	 pathology	 in	 Atg16l1VC	293	 mice	(Fig.	6	C;	Fig.	S4	A,	B,	C).	Finally,	in	these	experiments	we	also	assessed	the	294	 influence	 of	αTNF	 treatment	 on	 apoptosis	 levels	 in	 IEC.	 We	 found	 that	αTNF	295	 treatment	 of	Atg16l1VC	mice	 led	 to	 a	marked	 reduction	 of	 TUNEL	 positive	 IEC	296	 (Fig.	6	D;	Fig.	S4	D),	as	well	as	decreased	levels	of	cleaved	caspase	8	in	IEC	lysates	297	 (Fig.	 6	 E-G).	 Indeed,	 αTNF	 treatment	 reduced	 the	 exacerbated	 apoptosis	298	 induction	in	IEC	of	Atg16l1VC	mice	during	chronic	colitis	to	the	levels	present	in	299	 IEC	 isolated	 from	 Atg16l1fl/fl	 littermates	 (Fig.	 6	 D-G).	 However,	 following	 TNF	300	 blockade,	some	reduction	of	pathology	was	also	observed	in	the	Atg16l1fl/fl	mice	301	
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and	pro-inflammatory	mediators	were	reduced	in	both	Atg16l1fl/fl	and	Atg16l1VC	302	 littermates	 at	 two	 weeks	 of	 colitis	 (Fig.	 6	 C;	 Fig.	 S4	 A,	 B,	 C,	 E,	 F),	 suggesting	303	 several	 modes	 of	 action.	 In	 contrast,	 treating	 established	 colitis	 at	 day	 6	 post	304	 colitis	 induction	 with	 αTNF	 resulted	 in	 reduction	 of	 pathology	 only	 in	 the	305	
Atg16l1VC	mice	(Fig.	S5	A-C)	and	this	correlated	with	reduced	expression	of	pro-306	 inflammatory	mediators	(Fig.	S5	D,	E).	307	 Overall,	 these	 findings	 confirm	 that	 TNF-induced	 apoptosis	 of	 autophagy-308	 deficient	 IEC	 is	 a	 key	 contributor	 to	 the	 exacerbated	pathology,	 as	 blockade	of	309	 the	TNF	pathway	attenuates	the	disease.		 	310	
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Discussion	311	 GWAS	studies	linked	polymorphisms	in	ATG16L1	and	other	autophagy	genes	to	312	 the	development	of	 IBD	 (Hampe	et	al.,	 2007;	Rioux	et	al.,	 2007),	 suggesting	an	313	 important	 role	 of	 autophagy	 in	 IBD	 pathogenesis.	 However,	 despite	 extensive	314	 investigation,	 the	 mechanistic	 relationship	 between	 autophagy	 and	 intestinal	315	 inflammation	 is	 not	 fully	 understood.	 We	 performed	 comparative	 analyses	 to	316	 assess	 the	 consequences	 of	 autophagy	 deficiency	 within	 different	 cellular	317	 compartments	of	 the	 intestinal	mucosa.	We	 found	 that	autophagy	deficiency	 in	318	 LysM+	 or	 CD11c+	 cells	 only	 marginally	 affected	 chronic	 colitis	 development,	319	 whereas	autophagy	deficiency	in	IEC	resulted	in	severely	exacerbated	pathology.	320	 This	 comparative	 approach,	 using	 tissue-specific	Atg16l1-deficient	mouse	 lines	321	 in	 the	 same	 disease	 model,	 highlights	 the	 pivotal	 role	 of	 autophagy	 in	322	 maintaining	epithelial	barrier	function	during	inflammation.		323	 Our	 results	 indicate	 that	 intestinal	 epithelial	 cells	 can	 function	 quite	 normally	324	 without	autophagy,	as	long	as	intestinal	homeostasis	is	not	perturbed.	We	could	325	 not	detect	any	abnormal	growth	pattern,	differentiation	or	chemokine	response	326	 of	 Atg16l1-deficient	 IEC,	 nor	 altered	 susceptibility	 during	 acute	 Citrobacter	327	
rodentium	 infection	 in	Atg16l1VC	mice.	C.	 rodentium	 infection	 induces	 an	 acute	328	 and	self-limiting	epithelial	hyperplasia,	accompanied	by	mild	inflammation,	both	329	 of	which	abate	as	the	infection	is	cleared.	In	contrast,	the	H.	hepaticus	plus	anti-330	 IL-10R	 model	 results	 in	 sustained	 activation	 of	 innate	 and	 adaptive	 immune	331	 circuits	 that	 drive	 prolonged	 secretion	 of	 high	 concentrations	 of	 pro-332	 inflammatory	cytokines.	Under	the	severe	stress	conditions	present	during	this	333	 chronic	 colitis,	 Atg16l1-deficient	 IEC	 showed	 increased	 apoptosis,	 which	334	 contributed	to	exacerbation	of	intestinal	inflammation.	335	
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The	effects	of	autophagy-deficiency	in	IEC	have	been	studied	in	several	different	336	 models	and	mouse	strains	(Adolph	et	al.,	2013;	Benjamin	et	al.,	2013;	Cadwell	et	337	 al.,	 2008;	 Conway	 et	 al.,	 2013;	 Tschurtschenthaler	 et	 al.,	 2017).	 It	 has	 been	338	 reported	 that	 autophagy	 deficiency	 in	 IEC	 resulted	 in	 enhanced	 bacterial	339	 translocation	and	inflammation	following	acute	Salmonella	challenge	(Benjamin	340	 et	al.,	2013;	Conway	et	al.,	2013).	However,	when	we	evaluated	H.	hepaticus	DNA	341	 levels	 in	MLNs	of	mice	 in	the	chronic	colitis	model	(data	not	shown)	as	well	as	342	 systemic	 translocation	 of	 C.	 rodentium	 to	 liver	 and	 spleen	 following	 oral	343	 infection,	we	did	not	observe	elevated	levels	in	the	Atg16l1VC	mice	compared	to	344	
Atg16l1fl/fl	 mice.	 These	 results	 suggest	 that	 epithelial	 autophagy	 may	 be	345	 important	 for	 containing	 invasive	 intestinal	 pathogens,	 but	 is	 not	 essential	 for	346	 preventing	systemic	dissemination	of	non-invasive	pathogens.	347	 Several	 studies	 reported	 altered	 granule	 structure	 in	 autophagy-deficient	348	 secretory	IEC,	such	as	Paneth	cells	and	goblet	cells	(Adolph	et	al.,	2013;	Cadwell	349	 et	al.,	2008;	Lassen	et	al.,	2014;	Patel	et	al.,	2013).	This	phenotype	was	linked	to	350	 increased	pathology	in	norovirus	infected	Atg16l1	hypomorphic	mice	during	DSS	351	 colitis	(Cadwell	et	al.,	2010).	However,	whether	aberrant	Paneth	cell	morphology	352	 is	 a	 spontaneously	occurring	phenotype	 in	autophagy-deficient	 IEC	or	 requires	353	 an	additional	trigger	such	as	viral	or	bacterial	infection	or	ER	stress	is	not	clear	354	 (Adolph	 et	 al.,	 2013;	 Bel	 et	 al.,	 2017;	 Cadwell	 et	 al.,	 2008;	 Lassen	 et	 al.,	 2014;	355	 Patel	 et	 al.,	 2013).	 Furthermore,	 in	 IBD	 patients,	 altered	 granule	 structure	 in	356	 Paneth	cells	was	associated	with	the	ATG16L1	T300A	SNP	(Cadwell	et	al.,	2008).	357	 How	 this	 morphologic	 phenotype	 in	 the	 small	 intestine	 might	 predispose	 to	358	 colonic	 inflammation	 is	 poorly	 understood.	 Altered	 Paneth	 cell	 morphology	359	 could	 lead	 to	 altered	 AMP	 secretion,	 which	 might	 impact	 on	 microbiota	360	
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composition,	 a	 plausible	 factor	 for	 disease	 susceptibility.	 However	 it	 was	361	 recently	described	that	Atg16l1VC	mice	do	not	harbor	an	altered	tissue-adherent	362	 microbiota	in	the	ileum	compared	to	Atg16l1fl/fl	mice	(Tschurtschenthaler	et	al.,	363	 2017).	 In	our	study,	we	used	Atg16l1VC	and	Atg16l1fl/fl	 littermates	 to	avoid	any	364	 potential	 microbiota	 effects	 and	 to	 ensure	 that	 any	 differences	 in	 disease	365	 susceptibility	were	due	to	genotype.	366	 Several	 studies	 have	 illustrated	 compensatory	 mechanisms	 of	 ER	 stress	 and	367	 autophagy	in	intestinal	epithelial	cells.	Indeed,	transgenic	mice	lacking	both	the	368	 ER	 stress	 effector	 Xbp1	 and	 Atg16l1	 selectively	 in	 IEC	 develop	 severely	369	 exacerbated	levels	of	ER	stress	and	spontaneous	pathology	in	the	ileum	(Adolph	370	 et	 al.,	 2013;	 Tschurtschenthaler	 et	 al.,	 2017).	 Furthermore,	 these	 investigators	371	 also	reported	spontaneous	inflammation	in	the	ileum	of	aged	(>35weeks	of	age)	372	
Atg16l1VC	mice,	concomitant	with	enhanced	ER	stress	levels	(Tschurtschenthaler	373	 et	 al.,	 2017).	 During	 chronic	 colitis	 induction	 we	 observed	 elevated	 levels	 of	374	
Grp78	 in	 colonic	 IEC,	 indicative	 of	 enhanced	 ER	 stress,	 however	 we	 detected	375	 similar	 levels	 of	 Grp78	 in	 IEC	 isolated	 from	 Atg16l1fl/fl	 and	 Atg16l1VC	 mice,	376	 suggesting	 autophagy-independent	 regulation	 of	 ER	 stress	 during	 colonic	377	 inflammation.	Moreover,	ex	vivo	primary	colonic	 IEC	organoids	stimulated	with	378	 inflammatory	 cytokines	 or	 infected	 with	 H.	 hepaticus	 exhibited	 ER	 stress	379	 responses	 that	 were	 independent	 of	 the	 Atg16l1	 genotype.	 These	 findings	380	 suggest	 that	 autophagy	 and	 ER	 stress	 responses	 are	 only	 under	 certain	381	 conditions	 compensatory	 and	 could	 have	 different	 regulatory	 functions	 in	 the	382	 epithelium	of	the	small	intestine	and	colon.		383	 Our	study	reveals	a	link	between	autophagy	and	apoptosis	in	IEC.	We	found	that	384	 autophagy-deficiency	in	IEC	enhanced	apoptosis	induction	during	inflammatory	385	
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conditions,	thereby	potentially	weakening	the	barrier	integrity.	Furthermore,	we	386	 observed	 that	 Ag16l1-deficient	 IEC	 organoids	 were	 hyper-susceptible	 to	 TNF-387	 induced	 apoptosis.	 Similarly,	 during	 chronic	 colitis	 we	 observed	 that	 high	388	 intestinal	TNF	levels	were	associated	with	increased	numbers	of	apoptotic	IEC	in	389	
Atg16l1VC	 mice,	 but	 not	 Atg16l1fl/fl	 littermates.	 Of	 note,	 experimental	390	 administration	 of	 TNF	 also	 induced	 elevated	 levels	 of	 apoptosis	 in	 small	391	 intestinal	epithelial	cells	of	Atg16l1VC	mice,	confirming	an	intrinsic	control	of	IEC	392	 apoptosis	by	autophagy.	Indeed	blocking	TNF	during	chronic	colitis	resulted	in	a	393	 specific	and	marked	reduction	of	IEC	apoptosis	in	Atg16l1VC	mice,	confirming	our	394	 hypothesis	that	the	exacerbated	pathology	was	caused	by	increased	apoptosis	of	395	 autophagy-deficient	 IEC	 under	 inflammatory	 conditions.	 However,	 continuous	396	 blockade	 of	 TNF	 throughout	 chronic	 colitis	 resulted	 in	 reduced	 pro-397	 inflammatory	 chemokine	 levels	 and	 decreased	 intestinal	 pathology	 in	 both	398	
Atg16l1VC	and	Atg16l1fl/fl	mice,	which	indicates	that	TNF	also	has	additional	roles	399	 in	chronic	inflammation,	such	as	immune	cell	activation	and	survival	(Billmeier	400	 et	al.,	2016).	Furthermore,	although	treatment	of	already	established	colitis	with	401	
αTNF	does	not	reduce	pathology	in	WT	(Atg16l1fl/fl)	mice	(Kullberg	et	al.,	2001;	402	 West	et	al.,	2017),	we	found	that	it	attenuated	colitis	in	Atg16l1VC	mice,	indicating	403	 that	autophagy-deficiency	 in	 IEC	renders	the	disease	responsive	towards	αTNF	404	 treatment.	405	 In	 accordance	 with	 our	 results,	 a	 recent	 study	 reported	 that	 autophagy-406	 deficiency	also	renders	small	intestinal	epithelial	cells	hyper	susceptible	to	TNF-407	 induced	cell	death	(Matsuzawa-Ishimoto	et	al.,	2017).	These	investigators	used	a	408	 model	 of	 intestinal	 inflammation	 triggered	 by	 infection	with	murine	 norovirus	409	 and	 treatment	with	DSS,	 and	primarily	 focused	on	 the	 small	 intestine,	where	a	410	
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lack	 of	 autophagy	 led	 to	 increased	 susceptibility	 to	 necroptosis	 and	 a	 loss	 of	411	 Paneth	 cells	 (Matsuzawa-Ishimoto	 et	 al.,	 2017).	 In	 contrast,	 we	 observed	412	 exacerbated	 activation	 of	 caspase-8	 and	 caspase-3	 in	Atg16l1-deficient	 colonic	413	 IEC,	as	well	as	DNA	fragmentation,	all	of	which	are	hallmarks	of	apoptotic	death.	414	 Therefore,	 although	 autophagy	 appears	 to	 generally	 protect	 IEC	 from	 TNF-415	 induced	 cell	 death,	 there	may	 be	 differences	 in	 the	 dominant	 death	 pathways	416	 triggered	in	distinct	compartments	or	cell	types	(eg.	small	intestine	versus	colon;	417	 Paneth	 cells	 versus	 absorptive	 enterocytes),	 or	 during	 different	 types	 of	418	 inflammatory	challenge	(eg.	Norovirus	+	DSS	versus	H.	hepaticus	+	anti-IL-10R).	419	 These	results	are	consistent	with	previous	studies	in	which	epithelial	apoptosis	420	 has	 been	 linked	 to	 IBD	 pathology,	 with	 IEC	 having	 been	 described	 to	 be	421	 particularly	susceptible	to	TNF	induced	apoptosis	(Takahashi	et	al.,	2014;	Zeissig	422	 et	al.,	2004).	For	example,	in	a	mouse	model	of	spontaneous	ileitis	(SAMP1/YitFc	423	 model)	 a	 single	 shot	 of	 αTNF	 treatment	 ameliorated	 disease	 in	 the	 ileum	424	 correlating	with	reduction	of	epithelial	apoptosis	(Marini	et	al.,	2003).	Similarly,	425	 in	 the	 Atg16l1/Xbp1VC	 model	 of	 spontaneous	 enteritis,	 the	 pathology	 scores	426	 strongly	correlated	with	the	degree	of	epithelial	apoptosis	(Adolph	et	al.,	2013).	427	 Moreover,	 mice	 with	 hypomorphic	 expression	 of	 Atg16l1	 showed	 increased	428	 pathology	 with	 transmural	 inflammation	 in	 chemically	 induced	 colitis,	 which	429	 was	 reduced	 to	 wild-type	 levels	 by	 αTNF/	 αIFNγ	 treatment	 (Cadwell	 et	 al.,	430	 2010).	 Together	with	 these	 studies,	 our	 findings	 emphasise	 the	 links	 between	431	 autophagy	in	IEC	and	regulation	of	apoptosis	in	the	inflamed	intestine.	432	 	433	 Of	great	 interest	 is	whether	 IBD	patients	bearing	polymorphisms	 in	autophagy	434	 genes	present	with	increased	IEC	apoptosis	and	a	more	severe	disruption	of	the	435	
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epithelial	 barrier.	 Although	 the	 IBD	 associated	 ATG16L1	 T300A	 SNP	 does	 not	436	 confer	 loss	 off	 function	 under	 homeostatic	 conditions,	 it	 results	 in	 a	437	 destabilization	 of	 the	 protein	 by	 enhancing	 caspase	 3	 dependent	 degradation	438	 (Murthy	et	al.,	2014).		Therefore,	under	inflammatory	conditions	the	T300A	SNP	439	 will	 enhance	 degradation	 of	 ATG16L1	 and	 may	 thereby	 make	 the	 IEC	 more	440	 susceptible	to	apoptosis.	Interestingly,	αTNF	treatment	of	IBD	patients	has	been	441	 linked	to	reduction	of	IEC	apoptosis	(Zeissig	et	al.,	2004),	therefore	a	key	future	442	 issue	is	to	determine	whether	patients	that	harbor	genetic	predisposition	for	IEC	443	 apoptosis	 show	 better	 responsiveness	 to	αTNF	 treatment.	 For	 example,	 it	 has	444	 been	shown	that	SNPs	in	A20,	an	inhibitory	regulator	of	TNF	signaling	correlate	445	 with	αTNF	responsiveness	of	patients	(Vereecke	et	al.,	2014).	In	this	context,	it	is	446	 striking	that	a	recent	study	reported	a	correlation	between	the	ATG16L1	T300A	447	 SNP	and	a	beneficial	outcome	in	colon	cancer	(Grimm	et	al.,	2016),	which	might	448	 be	a	result	of	increased	apoptosis	susceptibility	of	IEC	harboring	the	SNP.		449	 Overall	our	study	proves	 that	 impaired	autophagy	 in	epithelial	cells,	but	not	 in	450	 myeloid	 cells,	 results	 in	 exacerbated	 chronic	 colonic	 inflammation.	We	 showed	451	 that	 autophagy-deficiency	 leads	 to	 enhanced	 cytokine-induced	 IEC	 apoptosis.	452	 The	potential	to	attenuate	the	exacerbated	pathology	in	Atg16l1VC	mice	by	αTNF	453	 treatment	is	of	great	clinical	interest	and	may	have	implications	for	treatment	of	454	 IBD	patients	harboring	SNPs	in	autophagy	genes.	 	455	
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Figure	legend	655	
Figure	1:	Epithelial	autophagy	dampens	chronic	colitis		656	
Atg16l1VC,		Atg16l1CD11c,	Atg16l1LysM	or	Atg16l1fl/fl		littermates	were	orally	infected	657	 with	 108	 CFU	 H.h.	 on	 3	 consecutive	 days	 and	 injected	 with	 1	 mg	 anti-IL10R	658	 weekly.	A)	Schematic	of	treatment	protocol.	B,	C)	Histopathology	of	the	caecum	659	 (B)	or	colon	(C)	was	assessed	on	day	14	and	presented	relative	to	the	respective	660	
Atg16l1fl/fl	littermates.	D,	E)	Representative	H&E	sections	of	caecum	(D)	or	colon	661	 (E)	 from	 Atg16l1VC	 or	Atg16l1fl/fl	 littermates	 at	 day	 14.	 F,	 G)	 Histopathology	662	 scores	of	the	caecum	(F)	and	colon	(G)	of	Atg16l1VC	and	Atg16l1fl/fl		littermates	at	663	 2	and	4	weeks.	H)	Weight	curves	of	Atg16l1VC	and	Atg16l1fl/fl		littermates	during	664	 chronic	 colitis.	 I)	Total	 numbers	 of	 CD4+TCRβ+	 T	 cells	 in	 isolated	 colonic	 LPLs	665	 from	 Atg16l1VC	 and	Atg16l1fl/fl	 littermates	 at	 steady-state	 and	 at	 day	 14	 after	666	 colitis	 induction.	 J-L)	 TNF	 (J),	 IFNγ	 (K)	 and	 IL-1β	 (L)	 levels	 in	 colonic	 organ	667	 culture	 supernatants	 from	Atg16l1VC	 and	Atg16l1fl/fl	 	 littermates	 at	 steady-state	668	 and	at	day	14	after	colitis	induction.	669	 	670	 Data	 are	 combined	 from	 at	 least	 3	 independent	 experiments	 (B,C,F,G,H,I)		671	 (representative	D,E)	or	2	 independent	experiments	(J,K,L).	Each	dot	represents	672	 an	 individual	 mouse	 (B,C,F,G,I,J,K,L),	 or	 data	 are	 shown	 as	 mean	 ±	 s.e.m	 (H).	673	 Horizontal	bars	denote	medians.	 Scale	bars	are	100	µm.	Statistical	 significance	674	 was	 determined	 using	 Kruskal-Wallis	 test	 with	 correction	 for	 multiple	675	 comparisons	 (B,	 C),	 two-way	 analysis	 of	 variance	 (ANOVA)	 with	 Bonferroni’s	676	 correction	 for	 multiple	 comparisons	 (H)	 or	 Mann	 Whitney	 test,	 *	 p<0.05;	 **	677	 p<0.01;	***	p<0.001.	ns	–	not	significant,	H.h.	–	Helicobacter	hepaticus,	p.i.	–	post	678	 infection.	 	679	
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Figure	 2:	Atg16l1-deficient	 IEC	 do	 not	 exhibit	 enhanced	 inflammatory	 or	680	
stress	responses	681	
A,	 B)	 qPCR	analysis	of	Cxcl2	 (A)	 and	Cxcl5	 (B)	 expression	 in	 IEC	 isolated	 from	682	
Atg16l1VC	 and	Atg16l1fl/fl	 	 littermates	 at	 day	 14	 after	 colitis	 induction.	C-K)	 IEC	683	 from	 Atg16l1VC	 and	 Atg16l1fl/fl	 mice	 were	 grown	 ex	 vivo	 in	 organoids.	684	 Inflammatory	conditioned	medium	(iCM)	was	harvested	from	LPL	cultures	from	685	 colitic	mice.	C)	Organoids	stimulated	with	10%	iCM	for	30	min	were	stained	for	686	 pSTAT3	(red)	and	STAT3	(green)	and	DAPI	 (blue).	D)	Atg16l1VC	and	Atg16l1fl/fl	687	 organoids	were	stimulated	with	10%	 iCM	 for	 indicated	 times	and	 lysates	were	688	 probed	with	antibodies	directed	against	indicated	proteins.		E,	F)	qPCR	analysis	689	 of	 Cxcl2	 (E)	 and	 Cxcl5	 (F)	 expression	 by	 Atg16l1VC	 and	Atg16l1fl/fl	 organoids	690	 treated	with	10%	iCM	for	6h.	G,	H)	Monolayers	of	Atg16l1VC	and	Atg16l1fl/fl	 IEC	691	 were	infected	with	H.h.	at	a	MOI	of	100:1.	G)	Lysates	were	blotted	after	indicated	692	 times	 for	 indicated	 proteins.	 H)	 qPCR	 analysis	 of	 Cxcl2	 expression	 by	 IEC	693	 monolayers	 after	 6h	 of	H.h.	 infection.	 I)	 qPCR	 analysis	 of	Grp78	 expression	 by	694	
Atg16l1VC	 and	 Atg16l1fl/fl	 organoids	 treated	 with	 10%	 iCM	 for	 12h.	 J)	 qPCR	695	 analysis	 of	 Grp78	 expression	 by	 Atg16l1VC	 and	Atg16l1fl/fl	 monolayers	 infected	696	 with	H.h.	(MOI	100:1)	for	6h.	K)	Lysates	of	Atg16l1VC	and	Atg16l1fl/fl	monolayers	697	 infected	with	H.h.	(MOI	100:1)	were	blotted	after	indicated	times	for	peIF2a	and	698	 eIF2a.	L,	M)	qPCR	analysis	of	Grp78	expression	in	whole	colonic	tissue	(L)	or	IEC	699	 (M)	 isolated	 from	 Atg16l1VC	 and	Atg16l1fl/fl	 littermates	 at	 day	 14	 after	 colitis	700	 induction.		701	 	702	 Data	 are	 representative	 of	 2	 (C,	 G,	 K)	 or	 3	 (A,	 B,	 D,	 L,	 M)	 independent	703	 experiments	or	combined	from	at	least	3	independent	experiments	(E,	F,	H,	I,	J).	704	
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Data	are	shown	as	medians	±	s.e.m	(E,	F,	H,	I,	J),	or	each	dot	represents	individual	705	 mouse	(A,	B,	L,	M).	Horizontal	bars	denote	medians.	Scale	bar	is	50	µm.	Statistical	706	 significance	was	determined	using	Mann	Whitney	 test,	 *	p<0.05;	 **	p<0.01;	 ***	707	 p<0.001.	iCM	–	inflammatory	conditioned	medium,	H.h.	–	Helicobacter	hepaticus.708	
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Figure	 3:	 Autophagy	 deficiency	 increases	 IEC	 apoptosis	 during	 chronic	709	
colitis	710	
Atg16l1VC	and	Atg16l1fl/fl	littermates	were	orally	 infected	with	108	CFU	H.h.	on	3	711	 consecutive	 days	 and	 injected	 with	 1	 mg	 anti-IL10R	 weekly.	A)	 TUNEL	 (red)	712	 stainings	 of	 caecum	 and	 mid	 colon	 sections	 isolated	 at	 day	 14	 after	 colitis	713	 induction.	Counterstaining	with	wheat	germ	agglutinin	(green)	and	DAPI	(blue).	714	
B,C)	Lysates	of	IEC	isolated	from	Atg16l1VC	and	Atg16l1fl/fl	littermates	at	1	week	715	 (B)	and	2	weeks	(C)	after	colitis	induction	were	blotted	for	cleaved	caspase	8.	D)	716	 Quantification	 of	 western	 blot	 bands	 of	 caspase	 8	 p43	 (upper	 panel)	 and	 p18	717	 (lower	 panel)	 in	 lysates	 of	 whole	 colon	 tissue	 isolated	 from	 Atg16l1VC	 and	718	
Atg16l1fl/fl	littermates	at	day	14	after	colitis	induction.	719	 	720	 Data	 are	 representative	 of	 3	 independent	 experiments	 (A-D).	 Each	 dot	721	 represents	individual	band	(D).	Horizontal	bars	denote	median.	Scale	bar	is	100	722	
µm.	ctl-	control,	Atg-	Atg16l1,	H.h.	–	Helicobacter	hepaticus.	 	723	
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Figure	4:	Autophagy	deficiency	predisposes	IEC	to	apoptosis		724	
Atg16l1VC	 and	Atg16l1fl/fl	 IEC	 were	 grown	 ex	 vivo	 in	 organoids.	 Inflammatory	725	 conditioned	medium	(iCM)	was	harvested	from	LPL	cultures	from	colitic	mice.	A,	726	
B)	Atg16l1VC	 and	Atg16l1fl/fl	 organoids	were	 stimulated	 for	 18h	with	 40%	 iCM	727	 (iCM);	iCM	plus	anti-TNF	(10µg/ml)	and	anti-IFNγ	(10µg/ml)	(iCM+αα);	or	with	728	 TNF	 (100ng/ml)	 and	 IFNγ	 (20ng/ml)	 (IFNγ +	 TNF).	 	 Cytotoxicity	 (A)	 and	729	 apoptosis	(B)	were	assessed	with	Apotox-Glo	(Promega	kit).	C,	D)	Atg16l1VC	and	730	
Atg16l1fl/fl	 IEC	 organoids	 were	 stimulated	 with	 TNF	 (100ng/ml)	 and	 IFNγ	731	 (20ng/ml)	 for	24h	prior	 to	 incubation	with	alamarBlue	 for	3h.	C)	Fluorescence	732	 intensity	 was	 measured	 at	 540nm/	 590nm,	 normalized	 to	 values	 prior	 to	733	 treatment	and	plotted	relative	 to	 the	untreated	genotype	control.	D)	Picture	of	734	 the	96-well	plate	after	further	24h	incubation	with	alamarBlue.	E)	Atg16l1VC	and	735	
Atg16l1fl/fl	 IEC	 organoids	 were	 stimulated	 with	 TNF	 (100ng/ml)	 and	 IFNγ	736	 (20ng/ml)	for	indicated	times	and	caspase	8	and	3	cleavage	detected	by	western	737	 blot.	 F)	 Atg16l1VC	 and	 Atg16l1fl/fl	 IEC	 organoids	 were	 stimulated	 with	 TNF	738	 (100ng/ml)	 and	 IFNγ	 (20ng/ml)	 for	 18h	 and	 cells	 were	 stained	 for	 cleaved	739	 caspase	3	(red),	the	epithelial	marker	E-cadherin	(green)	and	DAPI	(blue).	740	 	741	 Data	are	representative	of	3	independent	experiments	(A-F).	Data	are	shown	as	742	 mean	±	 s.e.m	 (A-C).	 Scale	bar	 is	50	µm.	Statistical	 significance	was	determined	743	 using	 students	 t	 test,	 *	 p<0.05;	 **	 p<0.01;	 ***	 p<0.001.	 iCM	 –	 inflammatory	744	 conditioned	medium,	αα	–	anti-TNF	and	anti-IFNγ,	T	–	TNF,	γ -	IFNγ.	 	745	
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Figure	5:	TNF	induces	epithelial	apoptosis	in	Atg16l1VC		mice		746	
Atg16l1VC	and	Atg16l1fl/fl	littermates	were	injected	intraperitoneally	with	10	μg	of	747	 TNF	 and	 sacrificed	 6h	 later.	A)	 Schematic	 of	 the	 treatment	 protocol.	B)	 Body	748	 weight	 at	 6h	 post-injection	 as	 percentage	 of	 initial	 weight.	C)	 TUNEL	 staining	749	 (red)	 of	 small	 intestinal	 sections;	 counterstaining	 with	 wheat	 germ	 agglutinin	750	 (green)	 and	 DAPI	 (blue).	 D,	 E)	 Representative	 western	 blot	 (D)	 and	751	 quantification	(E)	of	cleaved	caspase	8	in	isolated	IEC.		752	 	753	 Data	are	combined	(B,	E)	or	representative	(C,	D)	of	3	independent	experiments.	754	 Each	 dot	 represents	 individual	 mouse	 (B,	 E).	 Scale	 bar	 is	 100	 µm.	 Statistical	755	 significance	 was	 determined	 using	 Mann	 Whitney	 test,	 *	 p<0.05;	 **	 p<0.01.	756	 Horizontal	 bars	 denote	 medians.	 i.p.-	 intraperitoneal,	 WGA	 –	 wheat	 germ	757	 agglutinin,	cl.	casp8-	cleaved	caspase	8,	ctl-	control,	Atg	-	Atg16l1.		 	758	
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Figure	 6:	 TNF	 blockade	 attenuates	 colitis	 and	 IEC	 apoptosis	 in	Atg16l1VC	759	
mice	760	
Atg16l1VC	and	Atg16l1fl/fl		littermates	were	orally	infected	with	108	CFU	H.h.	on	3	761	 consecutive	days	and	injected	with	1	mg	anti-IL10R	i.p.,	with	some	cohorts	also	762	 receiving	1	mg	anti-TNF	i.p.	at	d0	and	d6.	A)	Schematic	of	the	treatment	protocol.	763	
B)	 Weight	 curves	 and	 C)	 representative	 micrographs	 of	 H&E	 stained	 colonic	764	 sections	 from	 Atg16l1VC	 and	 Atg16l1fl/fl	 littermates	 at	 day	 14	 after	 colitis	765	 induction.	D)	Representative	 images	of	TUNEL	(red)	staining	of	caecal	sections	766	 at	 day	 14	 after	 colitis	 induction;	 counterstaining	 with	WGA	 (green)	 and	 DAPI	767	 (blue).	E,	F,	G)	Western	blot	analysis	for	cleaved	caspase	8	in	colonic	IEC	lysates	768	 isolated	 from	 Atg16l1VC	 and	 Atg16l1fl/fl	 littermates	 at	 day	 14	 after	 colitis	769	 induction.	 Representative	 blot	 (E)	 and	 quantification	 of	 caspase	 8	 p43	 (F)	 and	770	 p18	(G)	relative	to	tubulin.		771	 	772	 Data	 are	 combined	 (B,	 F,	 G)	 or	 representative	 (C,	 D,	 E)	 from	 3	 independent	773	 experiments.	Each	dot	represents	an	individual	mouse	(F,	G),	or	data	are	shown	774	 as	 mean	 ±	 s.e.m	 (B).	 Scale	 bars	 are	 100	 µm.	 Statistical	 significance	 was	775	 determined	 using	 two-way	 analysis	 of	 variance	 (ANOVA)	 with	 Bonferroni’s	776	 correction	 for	 multiple	 comparisons.	 Results	 shown	 for	 comparison	 between	777	
Atg16l1VC	and	Atg16l1VC	+	αTNF	group	(B)	or	Mann	Whitney	test,	**	p<0.01;	***	778	 p<0.001,	****p<0.0001.	H.h.	–	Helicobacter	hepaticus,	pi	–	post	infection.		 	779	
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	STAR	Methods	780	
Contact	for	Reagent	and	Resource	Sharing	781	 Further	information	and	requests	for	resources	and	reagents	should	be	directed	782	 to	 and	 will	 be	 fulfilled	 by	 the	 Lead	 Contact,	 Dr.	 Kevin	 Maloy	783	 (kevin.maloy@path.ox.ac.uk).	784	 	785	
Experimental	model	and	subject	details	786	
Mice		787	
Atg16l1fl/fl	mice	 and	Atg16l1fl/fl	 Villin-Cre	 (Atg16l1VC)	mice	were	 generated	 and	788	 provided	 by	 the	H.	 Virgin	 laboratory	 (Washington	University,	 Saint	 Louis,	MO,	789	 USA),	 as	 described	 (Hwang	 et	 al.,	 2012).	 Atg16l1fl/fl	 mice	 were	 crossed	 to	790	 C57BL/6J-Tg	 (Itgax-cre,-EGFP)	 and	 Lyz2tm1(cre)	 to	 generate	 Atg16l1CD11c	 and	791	
Atg16l1LysM	mice.	 All	 above	 strains	 were	 bred	 and	 maintained	 under	 specific	792	 pathogen-free	conditions	and	tested	negative	for	Helicobacter	species.	Mice	were	793	 housed	 in	 groups	 of	 2-5	 in	 individually	 ventilated	 cages	 (IVC)	 and	 were	 6-12	794	 weeks	 old	 when	 used.	 All	 procedures	 on	 mice	 were	 conducted	 in	 accredited	795	 animal	facilities	at	the	University	of	Oxford	(Oxford,	UK)	in	accordance	with	the	796	 UK	 Scientific	 Procedures	 Act	 (1986)	 under	 a	 project	 license	 (PPL	 30/3423)	797	 authorized	by	the	UK	Home	Office	Animal	Procedures	Committee	and	approved	798	 by	the	local	ethical	review	panel.	Mice	were	bred	hemizygous	for	the	Cre	allele,	799	 resulting	 in	Atg16l1fl/fl	 Cre-	 and	Atg16l1fl/fl	 Cre+	 littermates.	 The	 colitis	 models	800	 show	 some	 variability	 over	 time	 and	 between	 cages,	 which	 suggest	 a	 strong	801	 contribution	 by	 the	 microbiota.	 Therefore,	 in	 all	 experiments	 age-	 and	802	 sex-matched	 littermates	 were	 used	 that	 were	 kept	 co-housed	 throughout	 the	803	 experiments.	Mice	were	allocated	to	experimental	groups	according	to	genotype,	804	
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litter	and	cage,	ensuring	that	in	every	cage	and	from	every	litter	both	genotypes	805	 were	present	and	treatment	regimes	were	evenly	distributed	over	cages.	806	 	807	
Organoid	culture	808	 Organoids	 were	 cultured	 as	 previously	 described	 by	 van	 den	 Brink	 and	809	 colleagues	(Heijmans	et	al.,	2013).	Colonic	crypts	were	isolated	from	Atg16l1fl/fl	810	 mice	or	Atg16l1VC	mice	and	seeded	 in	matrigel	 (Corning,	Wiesbaden,	Germany)	811	 and	cultured	 in	the	presence	of	N2	and	B27	supplements	(Fisher	Scientific-	UK	812	 Ltd,	 Loughborough,	 UK),	 mEGF	 (Fisher	 Scientific;	 50ng/ml),	 Y-27632	 (Sigma-813	 Aldrich,	 St.	 Louis,	 US;	 10uM),	 N-Acetylcysteine	 (Sigma-Aldrich,	 1mM)	 and	814	 conditioned	 medium	 containing	 Wnt3a	 (20%),	 Noggin	 (20%)	 and	 R-Spondin	815	 (10%).	 The	 conditioned	 media	 were	 generated	 from	 Rspol-Fc	 Hek	 293T	 cells	816	 (kind	 gift	 from	Dr.	 Calvin	Kuo,	 Stanford)	 and	Nog-Fc	Hek	 293T	 cells	 (kind	 gift	817	 from	Dr.	Gjis	van	den	Brink,	Amsterdam)	and	Wnt3A	L	cells	(ATCC®	CRL-2647™).	818	 After	expansion	by	several	passages	organoids	were	seeded	in	24	well	plates	for	819	 experiments	with	indicated	stimuli.		820	 For	 bacterial	 infection	 experiments,	 organoids	 were	 trypsinized,	 filtered	 and	821	 about	4	wells	(from	a	24-well	plate)	of	organoids	were	seeded	into	one	collagen-822	 coated	24-well	plate	well	 (Collagen-I,	A1048301,	ThermoFisher	Scientific).	The	823	 resulting	IEC	monolayers	were	cultured	in	complete	organoid	medium	for	2	days	824	 prior	to	infection.	 825	 	826	 	827	 	828	 	829	
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Method	details		830	
Colitis	models	831	
H.	hepaticus	 (NCI-Frederick	isolate	1A)	(Ward	et	al.,	1994)	was	cultured	in	TSB	832	 media	supplemented	with	10%	FCS	and	trimethoprim	(5µg/ml),	vancomycin	(10	833	
µg/ml)	 and	 polymyxin	 B	 (25	 IU/ml)	 (TVP,	 Oxoid)	 under	 microaerophilic	834	 conditions	 (10%	CO2,	10%	H2,	80%	N2)	 (Song-Zhao	and	Maloy,	2014).	Chronic	835	 colitis	was	induced	by	infecting	mice	intragastrically	with	108	CFU	H.	hepaticus	at	836	 3	consecutive	days	and	injecting	intraperitoneally	1	mg	of	mAb	anti-IL10R	(clone	837	 1B1.2)	weekly.	For	protection	experiments	mice	were	treated	with	1	mg	of	mAb	838	 anti-TNF	(XT3.11)	weekly.	839	 For	 infection	 experiments	 C.	 rodentium	 (ICC169)	 was	 grown	 in	 Luria	 Broth	840	 supplemented	with	nalidixic	acid	in	log	phase	to	an	OD	of	1.	Mice	were	infected	841	 intragastrically	with	5x109	CFU	C.	rodentium	(Song-Zhao	et	al.,	2014).	842	 	843	
TNF-induced	enteropathy	844	 Mice	were	injected	intraperitoneally	with	10	µg	of	murine	TNF	(Peprotech)	and	845	 scarified	after	6h	for	tissue	isolation.	846	 	847	
Histological	assessment	of	intestinal	inflammation	848	 Mice	were	 sacrificed	 at	 indicated	 time	 points	whereupon	 tissue	 sections	were	849	 fixed	 in	buffered	10%	formalin	and	paraffin-embedded.	Histological	analysis	of	850	 H&E	 stained	 sections	 for	 intestinal	 inflammation	 was	 performed	 as	 described	851	 (Song-Zhao	 and	 Maloy,	 2014).	 Briefly,	 inflammation	 was	 graded	 semi-852	 quantitatively	on	a	scale	from	0	to	3,	for	four	criteria;	(a) epithelial	hyperplasia	853	 and	 goblet	 cell	 depletion,	 (b)	 lamina	 propria	 leukocyte	 infiltration,	 (c)	 area	 of	854	
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tissue	 affected,	 and	 (d)	 markers	 of	 severe	 inflammation,	 including	 crypt	855	 abscesses,	 sub-	 mucosal	 inflammation,	 and	 ulceration.	 Scores	 for	 individual	856	 criteria	 were	 added	 up	 for	 an	 overall	 inflammation	 score	 between	 0	 and	 12.	857	 Scoring	was	performed	by	two	scientists	in	a	blinded	fashion.	858	
 859	
Isolation	of	cells	and	flow	cytometry	analysis	and	sorting	860	 For	 IEC	preparations	colons	were	 isolated	and	digested	 in	5mM	EDTA	 in	RPMI	861	 (5%	 FCS)	 for	 10	 min.	 Digests	 were	 vigorously	 shaken	 and	 cell	 suspension	862	 filtered.	 Cell	 pellets	 were	 lysed	 in	 RLT	 (Qiagen,	 Manchester,	 UK)	 for	 RNA	863	 preparation	or	RIPA	buffer	containing	proteinase	inhibitors	(Roche)	for	western	864	 blot	analysis.	Cell	 suspensions	 from	spleen,	mLN,	and	 intestinal	 lamina	propria	865	 were	 prepared	 as	 previously	 described	 (Uhlig	 et	 al.,	 2006).	 For	 intracellular	866	 cytokine	 staining	 cells	 were	 stimulated	 for	 3h	 with	 PMA	 (100	 ng/ml)	 and	867	 Ionomycin	 (1	 µg/ml)	 in	 the	 presence	 of	 Brefeldin A	 (10	 µg/ml).	 For	 FACS	868	 analysis	 the	 following	 antibodies	 from	 eBioscience	 (Hatfield,	 UK)	 were	 used:	869	 anti-CD4	 (GK1.5),	 anti-TCRβ	 (H57-597),	 anti-CD45	 (30-F11),	 anti-GR.1	 (RB6-870	 8C5),	 anti-Foxp3	 (FJK-16s),	 anti-IFN-γ	 (XMG1.2),	 anti-IL-17A	 (eBio17B7).	 The	871	 following	antibodies	were	from	BioLegend	(San	Diego,	USA):	anti-F4/80	(BMB),	872	 anti-CD11b	 (M1/70).	 Fixable	 Viability	Dye	 from	 eBioscience	was	 used	 to	 stain	873	 dead	 cells.	 For	 data	 acquisition	 a	 Cyan	 ADP	was	 used	 (Beckman	 Coulter,	 High	874	 Wycombe,	UK)	and	analyzed	using	FlowJo	software	(Tree	Star,	Ashland,	USA).	To	875	 verify	 excision	 efficiency	 of	 Atg16l1	 in	 distinct	 cellular	 population	 of	 the	876	 intestinal	 mucosa,	 cells	 were	 sorted	 with	 a	 MoFlo	 Astrios	 Sorter	 (Beckman	877	 Coulter).	LPL	were	stained	with	viability	dye	(eFluor	780),	anti-CD45-APC,	anti-878	 CD11c-Fitc,	 anti-MHC2-eFluor450,	 anti-CD11b-PerCP	 Cy5.5,	 anti-CD64-PE	 and	879	
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two	populations	were	collected	in	RLT	buffer:	DC	defined	as	live,	CD45+,	CD11c+	880	 and	MHC2+	and	macrophages	as	live,	CD45+,	CD11b+	and	CD64+.		881	 	882	
Immunofluorescent	stainings	883	 Colonic	 tissue	 samples	 were	 formalin-fixed	 and	 paraffin-embedded.	 Sections	884	 were	deparaffinized,	 rehydrated,	proteinase	k	 treated	and	stained	according	 to	885	 the	 in	situ	cell	death	detection	kit,	Fluorescein	(Sigma-Aldrich).	Counterstaining	886	 was	performed	with	Wheat	Germ	Agglutinin,	Alexa	Fluor	647	Conjugate	(Fisher	887	 Scientific)	 and	 DAPI	 (Sigma-Aldrich).	 Slides	were	mounted	with	 ProLong	 Gold	888	 Antifade	Mountant	(Fisher	Scientific).		889	 For	 immunofluorescent	 staining	of	 organoids,	 cells	were	 grown	on	 cover	 slips.	890	 Following	 stimulation	 cells	 were	 fixed	 with	 4%	 paraformaldehyde	 at	 room	891	 temperature	followed	by	methanol	treatment	at	-20C.	Cells	were	blocked	in	5%	892	 goat	 serum,	 5%	 BSA	 and	 0.5%	 saponine.	 Stainings	 were	 performed	 with	 pAb	893	 mouse-anti-Ecadherin	 (BD	 Bioscience),	 rabbit-anti-phospho	 Stat	 3,	 mouse-anti	894	 Stat	3	and	rabbit-anti-cleaved	caspase	3	from	Cell	Signalling	(Danvers,	USA)	and	895	 goat-anti-rabbit	 Alexa	 Fluor	 555	 or	 goat-anti-mouse	 Alexa	 Fluor	 488	 (Fisher	896	 Scientific).	 Images	were	 acquired	with	 an	 Olympus	 Fluoview	 FV1000	 confocal	897	 microscope	 and	 Olympus	 Fluoview	 Software	 (Olympus,	 Tokyo,	 Japan).	 One	898	 representative	 image	of	the	TUNEL	stained	sections	per	mouse	was	taken	after	899	 careful	screening	of	all	sections	while	blinded	for	the	genotype.	We	then	grouped	900	 the	 images	 according	 to	 the	 treatment/	 genotype	 and	 a	 different	 still	 blinded	901	 scientist in	 terms	of	genotype	or	treatment	chose	the	representative	 image	per	902	 group.		903	
 904	
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Western	blot	analysis	905	 For	 immunoblot	 analysis	 cells	were	 lysed	 after	 indicated	 times	 in	 RIPA	 buffer	906	 and	 1-5	 ug	 total	 protein	 were	 analyzed	 per	 lane.	 For	 detection	 the	 following	907	 primary	 antibodies	were	 used:	 anti-LC3	 antibody	 (L7543;	 Sigma-Aldrich)	 anti-908	 phospho-Stat3,	 anti-Stat3,	 anti-phospho-ERK1/2,	 anti-phospho-Mek,	 anti-909	 phospho-p65,	 anti-p65,	 anti-phospho-eIF2a,	 anti-eIF2a,	 anti-phospho-p38,	 anti-910	 cleaved	 caspase	8,	 anti-cleaved	 caspase	3,	 	 (all	 antibodies	 from	Cell	 Signalling)	911	 and	anti-tubulin	antibody	(sc5286,	Santa	Cruz	Biotechnology,	Dallas,	USA),	and	912	 secondary	HRP	conjugated	anti–rabbit	or	anti-mouse	antibody	(Cell	Signalling).		913	 	914	
Cell	death	and	metabolic	assay	915	 For	cell	death	detection	the	ApoTox	Glo	Assay	from	Promega	(Southampton,	UK)	916	 was	 used.	 Organoids	were	 seeded	 in	 4ul	matrigel	 in	 a	 96	well	 pate;	 following	917	 stimulation	 the	 ApoTox	 Glo	 Assay	 was	 used	 according	 to	 manufactures	918	 instructions.		919	 For	the	assessment	of	metabolic	activity	with	AlamarBlue	(Fisher	Scientific)	as	a	920	 correlate	 of	 cell	 viability	 organoids	 were	 seeded	 in	 4ul	 matrigel	 in	 a	 96	 well	921	 plate.	Organoids	were	incubated	with	AlamarBlue	for	3h	prior	to	stimulation	to	922	 generate	 reference	 metabolic	 activity.	 Fluorescent	 intensity	 was	 measured	 at	923	 540nm/	590nm.	Following	stimulation	same	procedure	was	repeated	and	values	924	 were	normalized	to	untreated	values.		925	 	926	
RNA	and	qPCR	927	 For	qPCR	analysis	cells	were	lysed	in	RLT	and	RNA	purified	using	the	RNeasy	kit	928	 from	 Qiagen.	 1-2	 µg	 of	 RNA	 were	 reverse	 transcribed	 with	 SuperScript	 III	929	
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reverse	 transcriptase	 (Fisher	 Scientific)	 and	 quantitative	 real-time	 PCR	 was	930	 carried	 out	 with	 the	 StepOnePlus	 Real	 time	 system	 from	 Applied	 Biosystems.	931	 RNA	 from	 sorted	 cell	 populations	 was	 purified	 with	 the	 RNeasy	 Micro	 kit	932	 (Qiagen)	 and	 all	 RNA	 was	 transcribed.	 qPCR	 Mastermix	 (Eurogentec,	 Liege,	933	 Belgium)	was	used	 for	Taqman	reactions	and	 iQ	Sybr	Green	Supermix	 (Biorad,	934	 Kidlington,	 UK)	 for	 Sybr	 green	 reactions.	 Taqman	 probes	 for	 Cxcl2	935	 (Mm_00436450_m1),	 Atg16l1	 (Mm_00513084_m1)	 and	 Hprt	936	 (Mm_03024075_m1)	 were	 from	 Applied	 Biossystems	 and	 primers	 for	 Grp78	937	 (forwards:	 acttggggaccacctattcct;	 reverse:	 atcgccaatcagacgctcc)	 for	 Sybr	 green	938	 PCR	from	Sigma-Aldrich.	Relative	expression	was	analysed	according	to	the	Pfaffl	939	 method	(Pfaffl,	2001).	940	 	941	
Organ	explants	942	 Pieces	of	10-20	mg	of	colon	or	caecum	were	 isolated	and	cultured	 in	complete	943	 RPMI	 (10%	 FCS,	 5µM	 β-mercaptoethanol	 (Fisher	 Scientific),	 1x	944	 Penicillin/Streptomycin	 (Fisher	Scientific),	1x	Glutamine	 (Fisher	Scientific))	 for	945	 20h.	 Supernatants	were	 tested	 for	 cytokine	 levels	with	 the	 Luminex	Multiplex	946	 Assay	(Thermo	Fisher	Scientific)	and	normalised	to	input	tissue	weight.	947	 	948	
Generation	of	inflammatory	conditioned	medium	(iCM)	949	 Lamina	propria	leukocytes	were	isolated	from	C57Bl/6	mice	at	2	weeks	of	H.h.	+	950	
αIL10R	 colitis	 and	 2.3x106	 cell/ml	 were	 seeded	 in	 complete	 RPMI	 for	 20h.	951	 Supernatants	from	cells	of	7	mice	were	pooled	and	frozen	at	-80C.	952	
	953	
	954	
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Quantification	and	statistical	analysis	955	 For	 weight	 curves	 p-values	 were	 determined	 by	 two-way	 ANOVA	 with	956	 Bonferroni	 post-tests.	 For	 other	 experiments,	 p-values	 were	 determined	 by	957	 nonparametric	Mann–Whitney	test,	or	by	Kruskal-Wallis	test	with	correction	for	958	 multiple	comparisons.	Differences	were	considered	statistically	significant	when	959	 p	<	0.05	 (*	 p<	 0.05,	 **	 p<	 0.01,	 ***	 p<	 0.001).	 Statistics	 were	 calculated	 using	960	 GraphPad	 Prism	 6	 software.	 The	 statistical	 tests	 applied,	 definition	 of	 center,	961	 dispersion	 and	 precision	 measures	 depicted,	 as	 well	 as	 the	 number	 of	962	 experimental	repeats	are	specified	in	the	figure	legends.	963	 For	 in	 vivo	 experiments,	 sample	 size	was	 determined	 by	 power	 analysis	 using	964	 power	 of	 trial	 software,	 which	 calculates	 a	 power	 value	 based	 on	 X2	 test	965	 statistics.	Calculated	required	sample	sizes	were	applied	whenever	possible.		966	
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Figure S1. Related to Figure 1. Detailed analysis of Atg16l1LysM, Atg16l1CD11c  and Atg16l1VC  mice.
A-C) Verification of Atg16l1 deletion in distinct compartments of the intestinal mucosa in Atg16l1CD11c, Atg16l1LysM, Atg16l1VC and 
Atg16l1fl/fl mice. qPCR analysis of Atg16l1 expression from IEC washes (A) or on sorted DC (B) and macrophage (C) populations from 
LPL. Atg16l1CD11c, Atg16l1LysM or Atg16l1fl/fl mice were orally infected with 108 CFU H.h. on 3 consecutive days and injected with 1 mg 
anti-IL10R weekly and sacrificed at day 14 after colitis induction.  D, E) Histopathology scores of caecum (D) and colon (E) samples 
from Atg16l1LysM and Atg16l1fl/fl littermates. F) Frequencies of cytokine positive CD4+TCRβ+ T cells in PMA, Ionomycin re-stimulated 
colonic LPLs from Atg16l1LysM and Atg16l1fl/fl littermates. G) Frequencies of Foxp3+ CD4+ TCRβ+ T cells in colonic LPLs from Atg16l1LysM 
and Atg16l1fl/fl  littermates. H, I) Histopathology scores of caecum (H) and colon (I) samples from Atg16l1CD11c and Atg16l1fl/fl 
littermates. J) Frequencies of cytokine positive CD4+ TCRβ+ T cells in PMA, Ionomycin re-stimulated colonic LPLs from Atg16l1CD11c and 
Atg16l1fl/fl littermates. K) Frequencies of Foxp3+ CD4+ TCRβ+ T cells in colonic LPLs from Atg16l1CD11c and Atg16l1fl/fl littermates.
Data are combined from 2 independent experiments (A-K). Bars represent means with SEM (A-C) or each dot represents individual 
mouse (D-K). Horizontal bars denote medians. Statistical significance was determined using Mann Whitney test, * p<0.05;  H.h. – 
Helicobacter hepaticus, pi – post infection.
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Figure S2. Related to Figure 1. Lamina propria leukocyte analysis of Atg16l1VC mice.
Atg16l1VC and Atg16l1fl/fl littermates were orally infected with 108 CFU H.h. on 3 consecutive days and injected with 1 mg 
anti-IL10R weekly. LPLs were analyzed by FACS at 2 weeks and 4 weeks after colitis induction. A-C) Prior to FACS staining LPLs 
were restimulated with PMA, Ionomycin and Brefeldin A for 3 h. Frequencies of IFN-γ+ (A), IL-17A+ (B) and IFN-γ+/ IL17A+  
cells of CD4+TCRβ+ T cells (C).  D) Frequencies of Foxp3+ cells of CD4+TCRβ+ T cells. E) Total numbers of Gr1high CD11bhigh cells 
in LPLs. F) H.h. DNA quantities were determined by qPCR in caecal content of Atg16l1VC and Atg16l1fl/fl littermates infected 
with H.h. only or treated with anti-IL10R weekly.
Data are combined from at least 3 independent experiments (A-E) or from 2 independent experiments (F). Each dot repre-
sents an individual mouse (A-F). Horizontal bars denote medians. Statistical significance was determined using Mann Whit-
ney test, * p<0.05; ctl – control, H.h. – Helicobacter hepaticus, p.i. – post infection.
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Figure S3. Related to Figure 1. Atg16l1VC mice do not show increased susceptibility to Citrobacter rodentium infection.
Atg16l1VC and Atg16l1fl/fl littermates were orally infected with 109 CFU C. rodentium. A) Weight was followed over 18 days. 
B) Spleen weights at day 8 and day 14 p.i.. C) Tissue adherent CFU in caecal tissue and D) CFU in faecal pellets of Atg16l1VC 
and Atg16l1fl/fl littermates at day 8 and day 14 p.i.. E, F) Histopathology scores of the caecum (E) and distal colon (F) of 
Atg16l1VC and Atg16l1fl/fl littermates at day 8 and day 14 p.i..  
Data are combined from 2 independent experiments (A-F). Each dot represents an individual mouse (B-F) or mean ± S.E.M. 
(A). Horizontal bars denote medians. Statistical significance was determined using Mann Whitney test. CFU- colony forming 
units, p.i. – post infection.
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Figure S4. Related to Figure 6. TNF blockade attenuates colitis and epithelial apoptosis in Atg16l1VC mice. 
Atg16l1VC and Atg16l1fl/fl littermates were orally infected with 108 CFU H.h. on 3 consecutive days and treated weekly with 1 mg 
anti-IL10R i.p. with indicated groups also receiving 1 mg anti-TNF i.p. at day 0 and day 6. Mice were sacrificed at day 14 after 
colitis induction. A) Representative micrographs of H&E stained caecal sections of Atg16l1VC and Atg16l1fl/fl littermates. B) Histo-
pathology scores of the caecum (B) and colon (C) of samples from Atg16l1VC and Atg16l1fl/fl littermates. D) Representative images 
of TUNEL (red) staining of colon sections, counterstaining with WGA (green) and DAPI (blue). E, F) qPCR analysis of expression of 
S100a8 (E) and Cxcl2 (F) in isolated IECs from Atg16l1VC and Atg16l1fl/fl littermates. Results were normalized to Hprt expression 
and expressed relative to the Atg16l1fl/fl group. 
Data are combined (B, C, E, F) or representative (A, D) of 3 independent experiments. Each dot represents an individual mouse 
(B, C, E, F). Horizontal bars denote medians. Statistical significance was determined using Mann Whitney test, * p<0.05; ** 
p<0.01. H.h. – Helicobacter hepaticus, p.i. – post infection. 
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Figure S5. Related to Figure 6. αTNF therapy attenuates pathology in Atg16l1VC mice.
Atg16l1VC and Atg16l1fl/fl littermates were orally infected with 108 CFU H.h. on 3 consecutive days and treated weekly 
with 1 mg anti-IL10R i.p. with indicated groups also receiving 1 mg anti-TNF i.p. at day 6 after colitis induction. Mice 
were sacrificed at day 14 after colitis induction. A) Schematic of the treatment protocol. B,C) Histopathology scores of 
the caecum (B) and colon (C) samples. D,E) Gene expression analysis of isolated IECs for S100a8 (D) and Cxcl2 (E). 
Results were normalized to Hprt expression and expressed relative to the Atg16l1fl/fl group. 
Data are combined from 3 independent experiments (B-E). Each dot represents an individual mouse (B-E). Horizontal 
bars denote medians. Statistical significance was determined using Mann Whitney test, * p<0.05; ** p<0.01; **** 
p<0.0001. H.h. – Helicobacter hepaticus. 
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